News for CANNABIS SCIENCE, INC. (CBIS)

News for CANNABIS SCIENCE, INC.
Date Headline
Jun 23, 2017 09:14 AM Cannabis Science Invests in the Research and Development of Cannabinoid-based Medications to Treat COPD and Asthma
Jun 22, 2017 08:43 AM UPDATE - Cannabis Science Releases the Chronic Pain CBIS Transdermal Patches to Meet the Overwhelming Demand from Self-Medicating Patients Worldwide as it Continues to Expands its California Dispensary Network
Jun 22, 2017 08:11 AM Cannabis Science Releases the Chronic Pain CBIS Transdermal Patches to Meet the Overwhelming Demand from Self-Medicating Patients Worldwide as it Continues to Expands its California Dispensary Network
May 26, 2017 08:16 AM Cannabis Science, Inc. Receives U.S. Federal Government Clearance to Receive U.S. Federal Government Contracts
May 11, 2017 09:02 AM Cannabis Science Releases First Test Batch of Suppositories to Aid Self-Medicating Patients That Require Alternative Delivery Methods With Severe Pain and Symptoms Related to Cancers, Anxiety, and Insomnia
May 02, 2017 08:35 AM Cannabis Science Senior Executives Chair Special Sessions and Deliver a Keynote Speech at the Global Health Catalyst Summit at Harvard Medical School
May 01, 2017 01:54 PM CBIS Stock: Potent Potential or Diluted Dud?
Apr 29, 2017 04:13 PM Cannabis Science Senior Executives Arrive at the Global Health Catalyst Summit at Harvard Medical School
Apr 27, 2017 09:32 AM Cannabis Science Selects Influential Southern California Financial Firm as the Lead to Raise the Proposed 25 Million USD in Expansion Capital and Boost its Industry Footprint
Apr 25, 2017 09:00 AM Cannabis Science 2017 Black Tie Gala for Cannabinoid Research Targeting Critical Ailments, Testimonials, Celebrity Interests, New Partnerships, and Loyalty Gift to Shareholders